Fluorinated poly(propylenimine) dendrimers as gene vectors.

The use of poly(propylenimine) (PPI) dendrimers as gene delivery vectors is limited by their low transfection efficacy and serious cytotoxicity. In this study, we prepare a series of efficient and low cytotoxic gene vectors based on PPI dendrimers using a facile fluorination strategy. Fluorinated G3, G4, and G5 PPI dendrimers show comparable or superior transfection efficacies to six representative transfection reagents such as Lipofectamine 2000, jetPEI, branched poly(ethyleneimine), SuperFect, PolyFect, as well as arginine-modified dendrimer on both HEK293 and HeLa cells. These fluorinated PPI dendrimers exhibit low cytotoxicity on the transfected cells because they achieve optimal transfection efficacy at extremely low nitrogen to phosphorus (N/P) ratios. In addition, the synthesized materials show high transfection efficacy on 3D multicellular spheroids. These results demonstrate that fluorination is a promising strategy to improve the transfection efficacy of PPI dendrimers while reducing the cytotoxicity of these cationic polymers.

[1]  Rongqin Huang,et al.  Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. , 2011, Biomaterials.

[2]  Chen Jiang,et al.  Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. , 2011, Biomaterials.

[3]  R. Kannan,et al.  Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. , 2010, Drug discovery today.

[4]  D. Tomalia Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry , 2005 .

[5]  E. Laurini,et al.  Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing. , 2013, Molecular pharmaceutics.

[6]  K. Ryan,et al.  Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system. , 2012, Biomaterials.

[7]  M. Ogris,et al.  Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Rongqin Huang,et al.  Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. , 2011, Biomaterials.

[9]  M. Breunig,et al.  Breaking up the correlation between efficacy and toxicity for nonviral gene delivery , 2007, Proceedings of the National Academy of Sciences.

[10]  T. Minko,et al.  Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[11]  W. Hennink,et al.  Polymers for gene delivery: Charged for success. , 2011, Nature materials.

[12]  Jong-sang Park,et al.  Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. , 2007, Biomaterials.

[13]  C. Liu,et al.  Structurally flexible triethanolamine-core poly(amidoamine) dendrimers as effective nanovectors to deliver RNAi-based therapeutics. , 2014, Biotechnology advances.

[14]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[15]  Donald A Tomalia,et al.  Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.

[16]  Chen Jiang,et al.  Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. , 2009, Biomaterials.

[17]  L. Tziveleka,et al.  Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agents. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Zhaozhong Jiang,et al.  Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. , 2011, Nature materials.

[19]  Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. , 2013, Angewandte Chemie.

[20]  Hongmei Wu,et al.  Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives. , 2012, Biomaterials.

[21]  D. Tomalia,et al.  CommentaryDendrimers in biomedical applications—reflections on the field☆☆☆ , 2012 .

[22]  Rui Guo,et al.  Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. , 2012, Biomaterials.

[23]  Clive J Roberts,et al.  Preferential liver gene expression with polypropylenimine dendrimers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Jiahai Zhang,et al.  Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity , 2011, International journal of nanomedicine.

[25]  G. Vassaux,et al.  Cancer-specific transgene expression mediated by systemic injection of nanoparticles. , 2009, Cancer research.

[26]  A. Schätzlein,et al.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. , 2005, Cancer research.

[27]  D. Stolz,et al.  Bifunctional compounds for targeted hepatic gene delivery , 2007, Gene Therapy.

[28]  Chen Jiang,et al.  Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. , 2009, Biomaterials.

[29]  Laurence Tetley,et al.  Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Jong-sang Park,et al.  Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Mingming Wang,et al.  A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios , 2014, Nature Communications.

[32]  D. Tomalia Interview: An architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix. , 2012, Nanomedicine.

[33]  L. Tetley,et al.  Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[34]  Franz Josef Gildehaus,et al.  Targeted Radioiodine Therapy of Neuroblastoma Tumors following Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene , 2009, Clinical Cancer Research.

[35]  Wenjun Yang,et al.  Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. , 2012, Journal of the American Chemical Society.

[36]  E. Wagner Strategies to Improve DNA Polyplexes for in Vivo Gene Transfer: Will “Artificial Viruses” Be the Answer? , 2004, Pharmaceutical Research.

[37]  Huixin He,et al.  Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes. , 2010, ACS nano.

[38]  Rui Peng,et al.  Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection. , 2011, Molecular pharmaceutics.

[39]  Meng Zheng,et al.  Non-viral gene transfection in vitro using endosomal pH-sensitive reversibly hydrophobilized polyethylenimine. , 2011, Biomaterials.

[40]  Sabrina Pricl,et al.  Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer. , 2012, Molecular pharmaceutics.

[41]  Brett A. Helms,et al.  Dendrimers at Work , 2006, Science.

[42]  L. Tetley,et al.  Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex. , 2011, Biomaterials.

[43]  A. Schätzlein,et al.  Dendrimers in gene delivery. , 2005, Advanced drug delivery reviews.

[44]  D. Tomalia Dendritic effects: dependency of dendritic nano-periodic property patterns on critical nanoscale design parameters (CNDPs) , 2012 .